Medical News

RSS

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

17 Nov 2009

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, announced that preclinical results for CYT997 were presented today in a poster by Cytopia Limited at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts.

17 Nov 2009

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria. The study will evaluate the safety, tolerability and pharmacokinetics of AN3365 in healthy volunteers.

17 Nov 2009

China Sky One Medical reports financial results for third-quarter 2009

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced record financial results for the third quarter of 2009.

17 Nov 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. Clifton Mining Company is a major shareholder in American Biotech Labs.

17 Nov 2009

Second-quarter fiscal 2010 results announced by China-Biotics

China-Biotics, Inc., a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for the second quarter of its 2010 fiscal year, ended September 30, 2009.

17 Nov 2009

Bayer's NEXAVAR approved in over 70 countries for the treatment of liver cancer

Bayer Inc. announced today that its international trial known as SHARP (Sorafenib HCC Assessment Randomized Protocol), led by Study Manager and Bayer Canada employee Tom Giannaris, has been selected as the winner in the 'Best International Trial' category for the Global Clinical Practice Journal Awards.

17 Nov 2009

BioCryst Pharmaceuticals announces sale of common stock shares

BioCryst Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, 5,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.

17 Nov 2009

AAPHP: E-cigarettes are not wildly dangerous alternatives as they have been portrayed

In July of this year, the Food and Drug Administration released a study that condemned electronic cigarettes as an unsafe alternative for smokers, but not all physicians are convinced that the study was accurate or even completely transparent to the tax payers that fund them.

17 Nov 2009

First Edition: November 17, 2009

Based on today's headlines, all eyes continue to be focused on the Senate -- where Democratic leaders are still waiting for the revised Congressional Budget Office analysis of their health bill and plotting about when to hold the first procedural vote on the measure.

17 Nov 2009

Presentations to highlight durability and efficacy of urethral bulking agents

Uroplasty, Inc. (AMEX: UPI), a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today announced that nine abstracts outlining study results submitted by various researchers have been accepted for presentation at the 2010 Annual Meeting of the Society for Urodynamics and Female Urology (SUFU), February 23-27, 2010 in St. Petersburg, FL. Presentations accepted were for both Uroplasty's Urgent® PC Neuromodulation System and Macroplastique® urethral bulking agent products.

17 Nov 2009

Go Travel Insurance urge gap year travellers to take out proper cover for swine flu

As swine flu threatens to make a resurgence, Go Travel Insurance have reinforced the need for gap year students to take out proper cover before they embark on their trip.

17 Nov 2009

Entellus Medical completes its Series D financing totaling $30MM

Entellus Medical, the Minnesota-based developer of novel, less invasive treatments for chronic conditions of sinusitis, has completed its Series D financing totaling $30MM. The Series D round was led by new investor Essex Woodlands Health Ventures and supported by existing investors Split Rock Partners and SV Life Sciences.

17 Nov 2009

United Regional Health Care System selects INX to deliver unified communications and wireless solution

INX, Inc., announced today that it has begun deployment of a unified communications and wireless solution for United Regional Health Care System in North Texas.

17 Nov 2009

Perceptive Informatics announces the expansion of its medical imaging capabilities for cardiology clinical trials

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials.

From Parexel 17 Nov 2009

IntelGenx completes first successful human study of an anti-migraine film

IntelGenx Corp. is pleased to announce the results of a clinical pilot study that suggests IntelGenx has successfully developed a product that is bioequivalent to a leading branded anti-migraine therapy. The product (INT008) has been developed using IntelGenx's proprietary immediate release film "VersaFilm" drug delivery technology. VersaFilm provides a patent-protected method of formulating in a convenient and discrete dosage form.

17 Nov 2009

Smith & Nephew launches new operative hysteroscopy device

Smith & Nephew's Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the United States.

17 Nov 2009

New website for senior care from A Softer Place

A Softer Place, LLC has announced the completion of Stage I of www.asofterplace.com. Refreshingly easy to use, straightforward, and timely, this Dallas-based website is the ultimate in online local advertising. It brings together only the very best senior care facilities, professionals and service providers in the area, in one comprehensive and informative directory; a “go to” place, where those who need help can find it quickly and easily with “two clicks” of the mouse.

17 Nov 2009

First phase of new electronic health record system launched at Trinity Center

NYU Langone Medical Center launched the first phase of its new electronic health record system last week at their multi-disciplinary faculty group practice at Trinity Center in lower Manhattan. The integrated system, powered by software from Epic Systems Corporation, provides a single platform from which physicians, staff and patients themselves can access and manage medical information.

17 Nov 2009

Omega Healthcare Investors signs securities purchase agreement with CapitalSource

Omega Healthcare Investors, Inc. (NYSE: OHI) today announced that it has entered into a securities purchase agreement with CapitalSource Inc. and several of its affiliates to purchase entities owning 80 long term care facilities (“Facilities”) for approximately $565 million. The purchase price includes a purchase option (“Option”) to acquire entities owning an additional 63 Facilities for approximately $295 million.

17 Nov 2009

Medical News

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

Anacor Pharmaceuticals commences patient dosing in AN3365 Phase I clinical study

China Sky One Medical reports financial results for third-quarter 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

Second-quarter fiscal 2010 results announced by China-Biotics

Bayer's NEXAVAR approved in over 70 countries for the treatment of liver cancer

BioCryst Pharmaceuticals announces sale of common stock shares

AAPHP: E-cigarettes are not wildly dangerous alternatives as they have been portrayed

First Edition: November 17, 2009

Presentations to highlight durability and efficacy of urethral bulking agents

Go Travel Insurance urge gap year travellers to take out proper cover for swine flu

Entellus Medical completes its Series D financing totaling $30MM

United Regional Health Care System selects INX to deliver unified communications and wireless solution

Perceptive Informatics announces the expansion of its medical imaging capabilities for cardiology clinical trials

IntelGenx completes first successful human study of an anti-migraine film

Smith & Nephew launches new operative hysteroscopy device

New website for senior care from A Softer Place

First phase of new electronic health record system launched at Trinity Center

Omega Healthcare Investors signs securities purchase agreement with CapitalSource

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News